NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

I told you AVII would not approve it Sentiment.

However... if the data were still un-blinded when they came up with a convincing major improvement in assessing progression, then I would like to think there would be a small chance that the FDA would consider the post analysis as supplemental data regarding MPFS against AVII's objections, and in spite of the irreversibility of the actual crossover. Note that such a post analysis is not guaranteed to favor DCVax-L because it is conceivable that a control patient would have pseudo-progression and have it confused as progression. Maybe never happens, but no law saying it can't happen.